WELL HEALTH TECHNOLOGIES CORP. EARLY WARNING NEWS RELEASE
WELL Health Technologies Corp. (WHTCF) has exercised its call option rights to acquire significant shares in HEALWELL AI Inc. The transaction occurred concurrent with HEALWELL's acquisition of Orion Health Holdings for approximately NZ$175 million on April 1, 2025.
Through the exercise of the Call Right, WELL acquired 30.8 million Subordinate Voting Shares and 30.8 million Multiple Voting Shares from HEALWELL's founding shareholders. Following the transaction, WELL now owns 97,473,161 HEALWELL Shares and 30,800,000 Multiple Voting Shares, representing approximately 37% of the economic interest and 69% of the voting rights in HEALWELL on a partially-diluted basis.
WELL Health Technologies Corp. (WHTCF) ha esercitato i suoi diritti di opzione per acquisire una quota significativa di azioni in HEALWELL AI Inc. La transazione è avvenuta in concomitanza con l'acquisizione di Orion Health Holdings da parte di HEALWELL per circa NZ$175 milioni il 1 aprile 2025.
Attraverso l'esercizio del diritto di opzione, WELL ha acquisito 30,8 milioni di azioni con diritto di voto subordinato e 30,8 milioni di azioni con diritto di voto multiplo dai soci fondatori di HEALWELL. A seguito della transazione, WELL possiede ora 97.473.161 azioni HEALWELL e 30.800.000 azioni con diritto di voto multiplo, che rappresentano circa il 37% dell'interesse economico e il 69% dei diritti di voto in HEALWELL su base parzialmente diluita.
WELL Health Technologies Corp. (WHTCF) ha ejercido sus derechos de opción para adquirir una participación significativa en HEALWELL AI Inc. La transacción se llevó a cabo simultáneamente con la adquisición de Orion Health Holdings por parte de HEALWELL por aproximadamente NZ$175 millones el 1 de abril de 2025.
A través del ejercicio del derecho de opción, WELL adquirió 30,8 millones de acciones con derecho a voto subordinado y 30,8 millones de acciones con derecho a voto múltiple de los accionistas fundadores de HEALWELL. Tras la transacción, WELL ahora posee 97.473.161 acciones de HEALWELL y 30.800.000 acciones con derecho a voto múltiple, representando aproximadamente el 37% del interés económico y el 69% de los derechos de voto en HEALWELL en una base parcialmente diluida.
WELL Health Technologies Corp. (WHTCF)는 HEALWELL AI Inc.에서 상당한 지분을 인수할 권리를 행사했습니다. 이 거래는 2025년 4월 1일 HEALWELL이 Orion Health Holdings를 약 1억 7500만 뉴질랜드 달러에 인수하는 것과 동시에 이루어졌습니다.
콜 옵션의 행사로 WELL은 HEALWELL의 창립 주주로부터 3,080만 주의 종속 투표 주식과 3,080만 주의 다수 투표 주식을 인수했습니다. 거래 이후 WELL은 현재 97,473,161 HEALWELL 주식과 30,800,000 다수 투표 주식을 보유하고 있으며, 이는 HEALWELL에서 경제적 이익의 약 37%와 투표권의 69%를 차지합니다.
WELL Health Technologies Corp. (WHTCF) a exercé ses droits d'option pour acquérir une participation significative dans HEALWELL AI Inc. La transaction a eu lieu en même temps que l'acquisition d'Orion Health Holdings par HEALWELL pour environ 175 millions NZD le 1er avril 2025.
Grâce à l'exercice du droit d'option, WELL a acquis 30,8 millions d'actions avec droit de vote subordonné et 30,8 millions d'actions avec droit de vote multiple auprès des actionnaires fondateurs de HEALWELL. Suite à la transaction, WELL possède désormais 97.473.161 actions HEALWELL et 30.800.000 actions avec droit de vote multiple, représentant environ 37% de l'intérêt économique et 69% des droits de vote dans HEALWELL sur une base partiellement diluée.
WELL Health Technologies Corp. (WHTCF) hat sein Optionsrecht ausgeübt, um einen bedeutenden Anteil an HEALWELL AI Inc. zu erwerben. Die Transaktion fand gleichzeitig mit der Übernahme von Orion Health Holdings durch HEALWELL für etwa 175 Millionen NZD am 1. April 2025 statt.
Durch die Ausübung des Optionsrechts erwarb WELL 30,8 Millionen nachrangige Stimmrechte und 30,8 Millionen Mehrfachstimmrechte von den Gründungsaktionären von HEALWELL. Nach der Transaktion besitzt WELL nun 97.473.161 HEALWELL-Aktien und 30.800.000 Mehrfachstimmrechte, was etwa 37% des wirtschaftlichen Interesses und 69% der Stimmrechte an HEALWELL auf einer teilweise verwässerten Basis entspricht.
- Gained controlling interest with 69% voting rights in HEALWELL AI
- Strategic acquisition concurrent with HEALWELL's NZ$175M Orion Health purchase
- Favorable call option exercise price of $0.125 per share
- Significant capital commitment required for share acquisition
- Increased exposure to HEALWELL AI's business risks
Exercise of Call Right
On October 1, 2023, WELL and the founding shareholders of HEALWELL AI Inc. ("HEALWELL"), Dr. Sven Grail ("Dr. Grail") and Dr. George Christodoulou ("Dr. Christodoulou"), entered into a call option agreement (the "Call Option Agreement"), under which WELL was granted a call option (the "Call Right") to acquire up to 30.8 million Subordinate Voting Shares of HEALWELL (each, a "HEALWELL Share") and 30.8 million Multiple Voting Shares of HEALWELL (each, a "MVS") from Dr. Grail and Dr. Christodoulou. Dr. Grail, together with his affiliates, owns 15.4 million HEALWELL Shares and 15.4 million MVSs subject to the Call Right and Dr. Christodoulou, together with his affiliates, owns 15.4 million HEALWELL Shares and 15.4 million MVSs subject to the Call Right (together, the "Optioned Shares"). The Call Right was exercisable until October 1, 2026 and its exercise was conditional on the achievement by HEALWELL of a number of performance milestones designed to demonstrate improvements in HEALWELL's financial and capital markets performance, as well as obtaining any required Toronto Stock Exchange or regulatory approvals. The Call Right could only be exercised in pairs, such that WELL had to concurrently acquire a HEALWELL Share and a MVS. Pursuant to the Call Option Agreement, on exercise of the Call Right, the price per security paid for the Optioned Shares was
Additional information with respect to the Call Option Agreement and its material terms can be found in WELL's early warning report dated October 1, 2023, and in WELL's Notice of Meeting and Management Information Circular dated August 21, 2023 which is available on www.sedarplus.ca.
On December 16, 2024, HEALWELL and Orion Health Holdings Limited ("Orion Health") entered into a share purchase agreement, pursuant to which HEALWELL agreed to acquire
WELL amended the terms of the Call Option Agreement to enable WELL to exercise the Call Right concurrent with the closing of the OHHL Acquisition (the "Closing"). Concurrently with the Closing, WELL exercised the Call Right.
Prior to the Closing and the exercise of the Call Right, WELL held beneficial ownership, directly or indirectly, or exercised control or direction over 65,923,161 HEALWELL Shares and 500,000 subscription receipts (each, a "Subscription Receipt"), each Subscription Receipt entitling WELL to receive, upon satisfaction of certain release conditions (namely, the closing of the OHHL Acquisition), and for no further consideration, one unit of HEALWELL, each unit consisting of one HEALWELL Share and one half of one share purchase warrant, with each whole share purchase warrant (each, a "Warrant") exercisable into one HEALWELL Share at the exercise price of
Immediately following the Closing and the exercise of the Call Right whereby all of the Optioned Shares were acquired by WELL, WELL owned, or exercise control or direction over 97,223,161 HEALWELL Shares, 30,800,000 MVSs and 250,000 Warrants.
HEALWELL had 261,547,371 HEALWELL Shares issued and outstanding on the Closing, following the issuance of 35,643,478 HEALWELL Shares to the vendor in the OHHL Acquisition, and 12,737,500 HEALWELL Shares in connection with the conversion of all 12,737,500 Subscription Receipts as part of the
WELL was approved as a control person of HEALWELL by resolutions of the shareholders of HEALWELL, on a disinterested basis, on September 21, 2023. The Toronto Stock Exchange subsequently approved WELL as a control person of HEALWELL on October 6, 2023.
WELL acquired the HEALWELL Shares and MVSs concurrent with the closing of the OHHL Acquisition and will hold the HEALWELL Shares and MVSs for investment purposes. WELL intends to review its investment in HEALWELL on a continuing basis and may, from time to time and at any time subject to compliance with applicable securities laws, and depending on market and other conditions, acquire or dispose of equity, debt or other securities of HEALWELL through open market transactions, private placements and other privately negotiated transactions, or otherwise, in each case, depending on a number of factors, including general market and economic conditions and other factors and conditions WELL deems appropriate.
WELL is incorporated under the laws of the Province of
A copy of WELL's early warning report dated April 1, 2025 will be made available on www.sedarplus.ca under HEALWELL's profile.
1 Includes 250,000 Warrants beneficially owned by WELL that will be convertible within 60 days of this report assuming the exercise of the Call Right.
View original content to download multimedia:https://www.prnewswire.com/news-releases/well-health-technologies-corp-early-warning-news-release-302417579.html
SOURCE WELL Health Technologies Corp.
FAQ
What is the significance of WELL Health's (WHTCF) recent share acquisition in HEALWELL AI?
How many shares did WELL Health (WHTCF) acquire from HEALWELL AI's founders?
What was the purchase price for WELL Health's (WHTCF) call option exercise?
How does HEALWELL AI's Orion Health acquisition relate to WELL Health's (WHTCF) share purchase?
